Clinical trial

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Name
BLI4700-202
Description
The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.
Trial arms
Trial start
2017-02-16
Estimated PCD
2017-04-10
Trial end
2017-04-10
Status
Completed
Phase
Early phase I
Treatment
BLI4700
BLI4700 Bowel Preparation (Investigational Regimen)
Arms:
BLI4700
Size
17
Primary endpoint
Proportion of Subjects With Successful Bowel Preparation
Day of colonoscopy
Eligibility criteria
Primary Inclusion Criteria: 1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication. 2. At least 18 years of age 3. If female, and of child-bearing potential, is using an acceptable form of birth control. 4. Negative urine pregnancy test at screening, if applicable 5. In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study Primary Exclusion Criteria: 1. Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon. 2. Subjects who had previous significant gastrointestinal surgeries. 3. Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with clinically significant electrolyte abnormalities based on Visit 1 laboratory results. 4. Subjects with a prior history of renal, liver or cardiac insufficiency 5. Subjects with impaired consciousness that predisposes them to pulmonary aspiration. 6. Subjects undergoing colonoscopy for foreign body removal and/or decompression. 7. Subjects who are pregnant or lactating, or intending to become pregnant during the study. 8. Subjects of childbearing potential who refuse a pregnancy test. 9. Subjects allergic to any preparation components. 10. Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures. 11. Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 17, 'type': 'ACTUAL'}}
Updated at
2023-11-15

1 organization

1 product

1 indication

Product
BLI4700
Indication
Colonoscopy